Publications
3 shownNiraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Among patients with newly diagnosed advanced ovarian cancer who had a response to platinum-based chemotherapy, those who received niraparib had significantly longer progression-...
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
In patients with advanced ovarian cancer receiving first-line standard therapy including bevacizumab, the addition of maintenance olaparib provided a significant progression-fre...
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 3
- Citations
- 5,662
- Institution
- Fondazione IRCCS Istituto Nazionale dei Tumori
External Links
Identifiers
- ORCID
- 0000-0003-0981-0598
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.